Table 1:
Number | X-waiver | No X-waiver | p-value | |
---|---|---|---|---|
PHYSICIAN CHARACTERSTICS | ||||
Age | ||||
Less than 30 | 24 (29%) | 2 | 22 | |
30–39 | 35 (42%) | 9 | 26 | |
40–49 | 15 (18%) | 6 | 9 | |
50–59 | 7 (8%) | 1 | 6 | |
Over 60 | 3 (4%) | 0 | 3 | p=0.149 |
Sex | ||||
Female | 32 (38%) | 5 | 27 | |
Male | 52 (62%) | 13 | 39 | p=0.309 |
Ethnicity | ||||
Hispanic/Latino | 4 (5%) | 0 | 4 | |
Non-Hispanic/Latino | 80 (95%) | 18 | 62 | p=0.573 |
Race | ||||
White | 62 (74%) | 13 | 49 | |
Black/African American | 0 (0%) | 0 | 0 | |
Asian | 13 (15%) | 4 | 9 | |
Other | 9 (11%) | 1 | 8 | p= 0.561 |
Level of Training | ||||
Intern | 8 (10%) | 0 | 8 | |
Resident | 29 (35%) | 4 | 25 | |
Attending | 47 (56%) | 14 | 33 | p=0.077 |
PGY5–9 | 18 (21%) | |||
PGY10–14 | 9 (11%) | |||
PGY15+ | 20 (24%) | |||
Percent Time in Clinical Care | ||||
Less than 20% | 2 (2%) | 1 | 2 | |
20–50% | 10 (12%_ | 1 | 9 | |
51–75% | 10 (12%_ | 3 | 7 | |
Greater than 75% | 61 (73%) | 13 | 48 | p=0.690 |
Close friend/family with SUD | ||||
Yes | 24 (29%) | 6 | 18 | p= 0.668 |
PRACTICE CHARACTERISTICS | ||||
X-waiver training completed | ||||
Yes | 18 (21%) | n/a | n/a | n/a |
Ordered Naloxone in past 3 months | ||||
Yes | 39 (46%) | 12 | 27 | p=0.052 |
Ordered Buprenorphine for a patient in past 3 months | ||||
Yes | 28 (33%) | 8 | 20 | p=0.259 |
Includes physicians who had an X-waiver (X-waiver) and those who had recently completed training but had not yet obtained an X-waiver (No X-waiver)
p-value for comparison of X-waivered vs non X-waivered physicians done using chi2 tests (p<0.05)